Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection by Katrijn Neyt et al.
August 2016 | Volume 7 | Article 3121
Original research
published: 16 August 2016
doi: 10.3389/fimmu.2016.00312
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Andreas Habenicht, 
Ludwig Maximilian University 
of Munich, Germany
Reviewed by: 
Fiona Jane Culley, 
Imperial College London, UK  
Cecilia Johansson, 




Bart N. Lambrecht  
bart.lambrecht@ugent.be
Specialty section: 
This article was submitted 
to Inflammation, 







Deswarte K, Hammad H and 
Lambrecht BN (2016) Early IL-1 
Signaling Promotes iBALT Induction 
after Influenza Virus Infection. 
Front. Immunol. 7:312. 
doi: 10.3389/fimmu.2016.00312
early il-1 signaling Promotes 
iBalT induction after influenza 
Virus infection
Katrijn Neyt1,2, Corine H. GeurtsvanKessel3, Kim Deswarte1,2, Hamida Hammad1,2  
and Bart N. Lambrecht1,2,4*
1 Laboratory of Immunoregulation, VIB Inflammation Research Center, Ghent, Belgium, 2 Department of Respiratory Medicine, 
Ghent University, Ghent, Belgium, 3 Department of Viroscience, Erasmus MC, Rotterdam, Netherlands, 4 Department of 
Pulmonary Medicine, Erasmus MC, Rotterdam, Netherlands
Inducible bronchus-associated lymphoid tissue (iBALT) is a long lasting tertiary lymphoid 
tissue that can be induced following influenza A virus (IAV) infection. Previous studies 
have shown that iBALT structures containing germinal center (GC) B cells protect against 
repeated infection by contributing locally to the cellular and humoral immune response. If 
we are to exploit this in vaccination strategies, we need a better understanding on how 
iBALT structures are induced. One hypothesis is that the strength of the initial innate 
response dictates induction of iBALT. In the present study, we investigated the role of 
interleukin (IL)-1 and IL-1R signaling on iBALT formation. Mice lacking the IL-1R had a 
delayed viral clearance and, thus, a prolonged exposure to viral replication, leading to 
increased disease severity, compared to wild-type mice. Contradictorily, iBALT formation 
following clearance of the virus was heavily compromised in Il1r1−/− mice. Quantification 
of gene induction after IAV infection demonstrated induction of IL-1α and to a much 
lesser extent of IL-1β. Administration of recombinant IL-1α to the lungs of wild-type 
mice, early but not late, after IAV infection led to more pronounced iBALT formation 
and an increased amount of GC B cells in the lungs. Bone marrow chimeric mice iden-
tified the stromal compartment as the crucial IL-1 responsive cell for iBALT induction. 
Mechanistically, Q-PCR analysis of lung homogenates revealed a strongly diminished 
production of CXCL13, a B cell-attracting chemokine, in Il1r−/− mice during the early 
innate phase of IAV infection. These experiments demonstrate that appropriate innate 
IL-1α–IL-1R signaling is necessary for IAV clearance and at the same time instructs the 
formation of organized tertiary lymphoid tissues through induction of CXCL13 early after 
infection. These findings are discussed in the light of recent insights on the pathogenesis 
of tertiary lymphoid organ formation in the lung in various diseases where the IL-1 axis is 
hyperactive, such as rheumatoid arthritis and COPD.
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inTrODUcTiOn
Influenza A virus (IAV) is a respiratory pathogen that causes seasonal or pandemic outbreaks with 
severe outcome in elderly and immune compromised patients. Epithelial cells are the first target cells 
for IAV infection (1, 2) and also coordinate the innate immune defense to prevent spreading of the 
virus, via production of type I interferons (IFNs). Interleukin (IL)-1α and IL-1β are among the first 
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cytokines that are secreted by epithelial cells and macrophages at 
sites of IAV replication (3). Secretion of IL-1β requires activation 
of the Nlrp3 inflammasome that leads to activation of caspase-1 
and cleavage of pro-IL-1β into IL-1β. Infection with IAV leads 
to activation of the Nlrp3 inflammasome in a process requiring 
the type I IFN-induced RNAse L/OAS system, while the virus 
actively suppresses IL-1β production and Nlrp3 activation via 
the NS1 protein (4–6). IL-1 induces the expression of endothelial 
adhesion molecules that promote the entry of innate inflamma-
tory cells like neutrophils, NK cells, dendritic cells (DCs), and 
monocytes resulting in a double effect on the host. On the one 
hand, it promotes survival by killing virus-infected cells, clear-
ing debris, and alarming the adaptive immune response. On the 
other hand, overzealous neutrophil recruitment can also cause 
inflammatory pathology that can ultimately lead to diffuse 
alveolar damage and death (6–10). Not surprisingly, the outcome 
of genetic deficiency of key components in IL-1 generation or 
signaling has been very different depending on the severity of the 
IAV infection (2, 9, 11).
Simultaneously with the activation of the innate immune 
response, adaptive immune responses are initiated in the 
draining lymph nodes by antigen-presenting migratory DCs. 
The architecture of lymph nodes promotes contact between 
antigen-presenting DCs and rare antigen-specific T cells and 
B cells of the adaptive immune system to maximize the immune 
response against a certain antigen. Antigen-specific T lympho-
cytes undergo clonal proliferation upon encounter with antigen 
presented by antigen-presenting cells and migrate back to the 
site of inflammation as T effector memory (TEM) cells or become 
central memory T cells (TCM) or T resident memory (TRM) cells 
(12). Antibody production is initiated from B lymphocytes that 
differentiate into plasmablasts, immediately, or become plasma 
cells after going through a germinal center (GC) reaction that 
promotes somatic hypermutation and affinity maturation of 
B cells (13).
The coordinated events of T and B cell activation induced by 
virus-laden DCs mainly occur in secondary lymphoid organs 
(SLOs) like lymph nodes and spleen that develop during embryo-
genesis at predefined areas, often at the crossroads of lymphatic 
vessels (14). However, highly organized structures of T and 
B cells can also be formed in the lung after birth as an adapta-
tion to the increased demand for a localized immune response. 
Various names, such as lymphoid tissue neogenesis, ectopic 
lymphoid tissue, and tertiary lymphoid structures have been 
used to describe these structures. Furthermore, they are often 
named after the anatomical region in which they occur. In the 
lungs, for example, lymphoid aggregations can often be found in 
close proximity to bronchi, and hence, these are called inducible 
bronchus-associated lymphoid tissues (iBALT). As they resemble 
SLOs anatomically and functionally, yet, only develop after birth 
as a result of chronic immune stimulation, they can also be called 
tertiary lymphoid organs (TLOs), even when found within the 
boundaries of another organ.
Tertiary lymphoid organs have been implicated in protection 
against IAV. Mice that lack SLOs can mount a rapid CD8 T cell 
response during IAV infection due to the induction iBALT (15), 
induced after clearance of IAV infection. Such TLO structures are 
generally formed in close proximity to bronchi after IAV infec-
tion, but can also be observed in the lung interstitium and are 
fully formed 17 dpi. iBALT structures that are induced in mice 
with functional lymph nodes can serve as an additional prim-
ing site for T cells (16) and can also contribute to the humoral 
immune responses (17). Once formed, iBALT structures can 
mount high affinity immune responses to other antigenic stimuli 
than the initiating stimulus due to the presence of GCs that allow 
somatic hypermutation and affinity maturation, complementing 
the immune response in the draining lymph nodes (16, 18). 
Furthermore, iBALT structures could be the perfect environ-
ment for depots of viral antigen that were described long after 
viral clearance and recovery from viral infection and possibly 
related to the induction or maintenance of virus-specific TRM 
cells (19, 20).
Despite morphological and functional similarities between 
SLOs and TLOs, the pathways that control formation and 
maintenance of TLOs are less clear. Generally, the molecular 
pathway that organizes T and B cells in discrete areas resembles 
the highly regulated inductive pathway for SLO development. 
Production of CCL19, CCL21, CXCL12, and CXCL13 by stro-
mal cells and B cells helps to organize and retain T and B cells in 
discrete areas (21–26). Also IL-7 seems required for TLO forma-
tion, e.g., in joints of rheumatoid arthritis patients and mouse 
models (27–30) and lungs of idiopathic pulmonary hyperten-
sion (IPAH) patients (31). It is more controversial which cells 
give the initial instruction for stromal cells to produce these 
chemokines. During SLO development in the fetal period, this 
is the distinct task of lymphoid tissue inducer (LTi) cells, a cell 
type that develops from Flt3+ and Flt3− α4β7 integrin-positive 
common progenitors that also forms innate lymphoid cells 
(ILC), and get expanded in response to Flt3L injections (32, 33). 
During formation of the lymph nodes and spleen, LTi cells 
provide signals for lymphoid organogenesis like lymphotoxin-
beta (LTβ) acting on the LTβR on stromal cells, but the precise 
signals might differ from organ to organ. Flt3l−/− mice for exam-
ple have reduced LTi cells and lack Peyer’s patches, but still have 
lymph nodes (33). However, research in Id2−/− and Rorc−/− mice, 
which lack LTi cells, showed that LTi cells were dispensable for 
the initial TLO induction after IAV infection or other forms of 
TLO induction (15, 34–38). Although LTi cells seem not strictly 
necessary for TLO induction, an instructive LTβ–LTβR signal 
remains essential for proper TLO development (25, 39). B cells, 
T cells, and DCs are heavily induced during inflammatory 
processes and all express LTα1β2 on their cell surface (17, 35, 
40, 41); therefore, they are perfect candidates to function as a 
substitute for LTi cells.
Whatever the precise molecular mechanisms of TLO induc-
tion might be, these TLO structures are virtually always seen 
at sites of inflammation. Yet, which inflammatory cytokines 
contribute to TLO induction is currently unknown. After many 
insults to the lung, including viral or bacterial infection, IL-1α 
and IL-1β are among the first cytokines to be secreted (3). IL-1 
secretion induces the expression of endothelial adhesion mol-
ecules that promote the entry of innate and adaptive immune 
cells and could, thus, promote TLO formation. On the other 
hand, it is also known that IL-1R−/− mice have a delayed viral 
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clearance and, thus, a longer exposure to viral particles (7). 
Chronic immune stimulation is often assumed to lead to TLO 
formation (42). If IL-1 limits viral replication, it could reduce the 
trigger for TLO induction.
In this paper, we addressed the role of IL-1 and IL-1R in TLO 
formation in the lung. We show that the iBALT-inducing events 
are initiated early after infection, long before the virus is cleared. 
More specifically, we show that early IL-1R signaling is necessary 
for proper IAV-associated iBALT and GC induction and that 




All experiments were approved by the independent animal 
ethics committee “Ethische Commissie Proefdieren – faculteit 
Wetenschappen Universiteit Gent en VIB-site Ardoyen” (identi-
fication number: EC 2013_070). Animal care and used protocols 
adhere to the Belgian Royal Degree of 29th May, 2013 for protec-
tion of experimental animals. European guideline 2010/63/EU is 
incorporated in this Belgian legislation.
Mice
C57Bl/6 mice (8–10  weeks) were purchased from Harlan 
Laboratories. IL-1R−/− mice were bred in-house and housed in 
specific pathogen-free housing.
To create chimeric mice, IL-1R−/− or wild-type acceptor mice 
were irradiated sublethally (9 Gy) and reconstituted with 2 × 106 
bone marrow cells i.v. from wild-type or IL-1R−/− donor mice 
respectively 4 h after irradiation. Mice were used for experiment 
at least 10 weeks after reconstitution.
influenza Virus infection
Mice were infected intranasally with 105 TCID50 H3N2 influenza 
virus X-31 (Medical Research Council) or mock (allantoic fluid of 
uninfected eggs); diluted in 50 μl PBS. Weight loss was monitored 
daily. For suppletion assays, mice were treated intratracheally 
with 80 μg carrier-free recombinant IL-1α (R&D) at 2 or 10 dpi.
TciD50 assay Viral Titers
Lungs were homogenized with a tissue homogenizer in 1 ml PBS 
and centrifuged (5 min, 400 g) to remove cellular debris before 
storage at −80°C. Titers of infectious virus were determined 
in triplicate by titration on MDCK cells in serum-free TPCK-
treated trypsin-containing medium. Viral titers were determined 
by measuring chicken red blood cell agglutination activity in the 
cell supernatant after 7 days of infection of MDCK cells by using 
the calculation method of Reed and Muench.
isolation of lung cells
Mice were sacrificed and the lungs were removed. Single-cell 
suspensions were prepared by digestion in collagenase/DNase 
solution for 30 min at 37°C. After digestion, the suspension was 
filtered over a 100 μm filter and red blood cells were lysed with 
osmotic lysis buffer (10 mM KHCO3, 155 mM NH4Cl, 0.1 mM 
EDTA in ddH2O).
Flow cytometry
Lung cells were stained extracelullarly with anti-CD3 (17A2, 
conjugated to AF700, eBioscience), anti-CD19 (1D3, conjugated 
to APC, BD Bioscience), anti-IgM (R6-60.2, conjugated to 
PerCp-Cy5.5, BD Bioscience), anti-IgD (11-26c.2a, conjugated to 
PE, BD Bioscience), anti-CD95 (Jo2, conjugated to PE-Cy7, BD 
Bioscience), anti-GL7 (GL7, conjugated to Fitc, BD Bioscience), 
and a fixable live-dead marker (conjugated to eFl506, eBioscience).
Acquisition of samples was performed on a LSR II or Fortessa 
cytometer equipped with FACSDiva software (BD biosciences). 
GC B cells were defined as CD3−CD19+IgM−IgD−CD95+GL7+. 
Final analysis and graphical output were performed using FlowJo 
software v9 (Tree Star, Inc.).
real-time Quantitative rT-Pcr
Quantitative RT-PCR for IL-1α, IL-1β, LTβ, CCL19, CCL21, 
CXCL12, and CXCL13 were performed on RNA obtained from 
whole lung homogenates. Total RNA was extracted using Tripure 
reagent (Roche) according to the manufacturer’s protocol. RNA 
was resuspended in diethyl-polycarbonate (DEPC, Sigma)-treated 
water. A total of 1 μg RNA was used for reverse transcription using 
the Transcriptor High Fidelity Reverse Transcriptase kit (Roche) 
according to the manufacturer’s protocol. The subsequent target 
amplification on triplicates of each cDNA sample was performed 
using the Universal Probe Library system from Roche, which 
contains fluorescent hydrolysis probes of eight locked nucleic 
acids (LNA). Primers were designed with the help of the web-
based application Probefinder (https://qpcr.probefinder.com), 
and a minimum of two primer pairs per target were analyzed. 
Primers were validated first using the LC480 SybrGreenI Master 
(Roche) with melting curve analysis (TM calling) in the LC480 
Software and then using the LC480 Probes Master. Aspecific 
primer pairs were discarded. Table 1 shows a comprehensive view 
of the primer/probe combinations chosen. PCR conditions were: 
5′ pre-incubation at 95°C followed by 45 amplification cycles of 
10″ at 95°C, 10″ at 60°C, and 20″ at 72°C using a Lightcycler 480 
(Roche). PCR amplifications for the housekeeping genes encod-
ing Hprt or L27 were performed during each run for each sample 
to allow normalization between samples.
histology
Lungs were inflated with 1 ml 1:1 PBS-OCT (Tissue Tec), snap 
frozen in liquid nitrogen and stored at −80°C. Frozen 8  μm 
sections were fixed in 4% PFA and blocked in a 1% blocking 
buffer (Roche).
Immunofluorescence staining was performed by stain-
ing for B220 (RA3-6B2, Rat-a-mB220 conjugated to PE, BD 
Bioscience + Goat-a-Rat conjugated to AF555, Invitrogen), CD4 
(RM4-5, Rat-a-CD4 conjugated to Fitc, eBioscience + Rab-a-Fitc 
conjugated to AF488, Invitrogen), CD8 (53-6.7, Rat-a-CD8 con-
jugated to Fitc, BD bioscience + Rab-a-Fitc conjugated to AF488, 
Invitrogen), CD11c (N418, Hamster-a-mCD11c conjugated to 
AF647, eBioscience), and GL7 (GL7, Rat-a-mGL7 Fitc, BD bio-
science + a-Fitc conjugated to HRP, Jackson + a-HRP conjugated 
to Fitc, Jackson). Where necessary, slides were incubated with 
10% normal rat serum to prevent aspecific binding of antibodies. 
TaBle 1 | Q-Pcr primers.
Target ensemble transcript Fwd primer rvs primer Probe #
CXCL12 ENSMUSG00000061353 GGTTCTTCGAGAGCCACATC TTCTTCAGCCGTGCAACA 21
CXCL13 ENSMUSG00000023078 CAGAATGAGGCTCAGCACAG ATGGGCTTCCAGAATACCG 80
CCL19 ENSMUSG00000071005 GGTGCCTGCTGTTGTGTTC CTGGTGCTGTTGCCTTTGT 29
CCL21 ENSMUSG00000094121 ACCCAAGGCAGTGATGGA GCTTCCGGGGTAAGAACAG 74
IL-1α ENSMUSG00000027399 TTGGTTAAATGACCTGCAACA GAGCGCTCACGAACAGTTG 52
IL-1β ENSMUSG00000027398 AAAGCTTGGTGATGTCTGGTC AAAGGACATGGAGAACACCACT 10
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Slides were counterstained with Dapi and digitized on a LSM710 
microscope (Zeiss). All depicted pictures are representative of 
at least five mice per group. Images were analyzed using Imaris 
software (Bitplane).
statistical analysis
All experiments were performed using three to six animals per 
group. All experiments were performed at least two times. The 
difference between groups was calculated using the Student’s 
t test for unpaired data (Prism version 6; GraphPad Software, 
Inc.). Data are depicted as mean ± SEM. Differences were con-
sidered significant when p < 0.05.
Analysis of the repeated relative body weight data was 
performed using the residual maximum likelihood (REML) 
as implemented in Genstat v17 (43). The following lin-
ear mixed model (random terms underlined) was fitted 
to the data: Yijkt  =  μ  +  genotypej + treatmentk + timet + 
(genotype⋅treatment)jk + (genotype⋅time)jt + (treatment⋅time)kt + 
(genotype⋅treatment⋅time)jkt + (mouse⋅time)it + residualijkt, where 
Yijkt is the relative body weight of i-th mouse having genotype j, 
k-treated, and measured at time point t (t = 3–17 days; unequally 
spaced) and μ is the overall mean calculated for all mice considered 
across all time points. A first order antedependence covariance 
structure was used to model the within-subject correlation. The 
significance of the comparison between WT-X31 and KO-X31 
across time was assessed by an F-test.
A log-linear model (Poisson distribution and log link) was 
fitted to the amount of viral particles measured by hemagglutina-
tion inhibiton assay. The dispersion parameter was set as free. 
Significance of main effects GENOTYPE and TIME and the 
GENOTYPE⋅TIME interaction effect was assessed by an F-test.
resUlTs
Il1r1−/− Mice have Prolonged Viral load 
but are Unable to induce iBalT
To assess the immune response to IAV infection in mice lacking 
signaling via IL-1R, we infected Il1r1−/− mice and monitored 
weight loss and viral load in the lungs. Wild-type mice showed 
maximum weight loss around 6 dpi, and bodyweight was fully 
restored around 10 dpi. Il1r1−/− mice lost weight with slower and 
prolonged kinetics, and reaching a nadir at 8 dpi. Like wild-type 
mice they did manage to gain weight again, but did not recover to 
their starting bodyweight before 17 dpi (Figure 1A). This differ-
ence in the weight loss curve was also reflected in the viral load in 
the lungs (Figure 1B). Viral load in wild-type mice peaked around 
6 dpi, yet was cleared at 8 dpi. Il1r1−/− mice had systematically 
higher viral loads during the entire course of infection and did 
not clear the infection completely at 8 dpi as an estimated remain-
ing titer of 100,000 viral particles is detected at this time point.
Viral clearance depends on induction of adaptive immunity 
by DCs that activate CD8 and CD4 T cells and a humoral 
immune response by B cells. Total numbers and kinetics of 
increase of T and B cells and conventional DCs were not altered 
in Il1r1−/− mice in response to IAV infection. Lung conventional 
DCs consist of various subsets that have different functions and 
can be discriminated based on cell surface markers CD11b and 
CD103 (44, 45). As soon as there is inflammation in the lung, 
monocytes can also be recruited and these can rapidly differenti-
ate into a MHCII+CD11c+ cell type (so called monocyte-derived 
DC, MoDC) that also expresses the macrophage marker CD64 
(46). In contrast to the conventional CD103+ and CD11b+ DCs, 
the accumulation of CD11c+CD64+ MoDCs was reduced in the 
lungs of Il1r1−/− mice (Figure 1C).
To evaluate the effect of the higher and prolonged viral expo-
sure on IAV-associated iBALT formation, we visualized iBALT 
structures in the lungs by hematoxilin staining. Generally, clusters 
of cells near the bronchi were more readily detected in wild-type 
mice than in Il1r1−/− mice (Figure 1D). Because a hematoxilin 
stain did not allow us to evaluate if the inflammatory clusters of 
cells were organized and immunologically active iBALT struc-
tures, we stained frozen lung sections for B cells, T cells, DCs, and 
GC B cells and analyzed them by confocal microscopy. In wild-
type mice, we could easily detect organized structures composed 
of B cells, T cells, and DCs and B cell aggregates that contain GC 
B cells, but we were unable to detect similar infiltrates in Il1r1−/− 
mice (Figure 1E). To quantify the presence or absence of iBALT 
structures we measured the proportion of GC B cells in the lungs 
at 17 dpi by flow cytometry as a measure for biologically active 
iBALT. As GL7+ GC B cells are not found in the lungs of mice in 
the absence of iBALT, we believe this is a good approximation of 
the amount of iBALT formed (17). Wild-type mice showed an 
induction of GC B cells upon IAV infection, but this induction 
was absent in Il1r1−/− mice (Figure 1F). Taken together, these data 
suggest that although Il1r1−/− mice had a higher and prolonged 
exposure to viral particles in the lung, they were unable to form 
organized iBALT structures in the lung, pointing to an essential 
role for IL-1 cytokines in TLO induction following influenza 
virus infection.
il-1α administration Promotes induction 
of iBalT structures in the lung
As the mere presence of viral particles was not enough to trig-
ger the iBALT initiation and IL-1R signaling was necessary, we 
FigUre 1 | Il1r1−/− mice have a prolonged viral load in the lungs, but do not develop iBalT structures. (a) Weight loss curve as percentage of the initial 
bodyweight for wild-type (squares) and Il1r1−/− mice (circles) that have been infected with mock (white) or X31 (black) virus. The significance of the comparison 
between WT-X31 and KO-X31 across time was assessed by an F-test (F < 0.001), differences between individual time points were assessed by a t test. (B) Viral 
titers in the lung of wild-type (white) or Il1r1−/− (black) mice determined by hemagglutination-inhibition assay after culture with MDCK cells. Significance of main 
effects GENOTYPE and TIME and the GENOTYPE⋅TIME interaction effect was assessed by an F-test (F = 0.022; F < 0.01; F = 0.984, respectively). (c) Numbers 
of T and B cells, CD103+ cDC1 and CD11b+ cDC2 DCs, and monocyte-derived cells (MoDC) in the lungs of wild-type (white) and Il1r1−/− mice (black).  
(D) Hematoxylin-stained lung sections 17 dpi of wild-type and Il1r1−/− mice. Images are representative for at least three mice per group. (e) Confocal images of 
lung sections of wild-type and Il1r1−/− mice at 17 dpi. Sections were stained with either B220 (red), CD11c (Green), CD3 (Gray) and dapi (blue) or B220 (red), GL7 
(Green), and dapi (Blue). Shown images are representative for five mice per group. (F) Proportion of germinal center B cells (GL7+) in the lungs of wild-type and 
Il1r1−/− mice infected with mock (white) or X31 (black) virus at 17 dpi determined by flow cytometry. All experiments were performed at least twice with 4–6 mice 
per group. *p < 0.05; **p < 0.01.
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quantified expression of IL-1α and IL-1β, which signal both 
via IL-1R, in the lungs after IAV infection. Both cytokines were 
induced after infection in a bimodal curve with a first peak 
around 4  dpi and a second, but smaller, peak around 10  dpi 
(Figure 2A). In general, the induction of mRNA for IL-1α was 
more pronounced compared with IL-1β.
We, next, addressed if administration of IL-1 cytokine would 
be enough to further boost iBALT induction in IAV-infected 
mice. Since IL-1α and IL-1β have similar effects on the IL-1R, and 
as induction of IL-1α was more pronounced after IAV infection, 
we chose to only administer IL-1α. When recombinant IL-1α 
was administered i.t. 2  days post IAV infection in wild-type 
mice, clustering of inflammatory cells could be detected more 
readily on lung sections compared to PBS-treated IAV-infected 
mice (Figure  2B). To quantify biologically active iBALT, we 
again quantified the proportion of GC B cells by flow cytometry. 
Administration of recombinant IL-1α at 2 dpi resulted in a higher 
proportion of GC B cells in the lungs 17 dpi compared to PBS 
FigUre 2 | early il-1α signaling is sufficient and necessary for iBalT induction. (a) mRNA expression of IL-1α (white) and IL-1β (black) relative to the 
housekeeping gene L27 in the lungs of wild-type mice. (B) Hematoxylin-stained lung sections 17 dpi of mice treated with PBS or recIL-1α 2dpi. Images are 
representative for at least three mice per group. (c) Proportion of germinal center B cells 17 dpi in the lungs of wild-type mice treated with PBS (white) or 
recombinant IL-1α (black) i.t. 2 or 10 dpi. All experiments were performed at least twice with 3–5 mice per group. ns, not significant. **p < 0.01.
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administration (Figure 2C). However, when the administration 
of recombinant IL-1α was only initiated at 10 dpi, no differences 
in the proportion of GC B cells could be observed between IL-1α 
and PBS-treated groups (Figure 2C). This suggests that early, but 
not late, IL-1R signaling is necessary and sufficient to promote 
GC B cell positive iBALT structures.
il-1r signaling on stromal cells is 
necessary to induce gc B cells
As early IL-1R signaling is necessary to induce iBALT structures 
in the lung, we sought to identify the cell type that is responsive 
to IL-1 signals. Therefore, we constructed bone marrow chimeric 
mice in which either the radiosensitive hematopoietic or the 
radioresistant stromal compartment was deficient for Il1r1. As 
a control, we also reconstituted Il1r1−/− mice with Il1r1−/− bone 
marrow as a substitute for intact Il1r1−/− mice and control for irra-
diation effects. Il1r1−/− mice that received wild-type bone marrow 
followed a weight loss curve characterized by a longer weight loss 
and slower recovery, as observed in Il1r1−/− mice. In contrast, 
wild-type mice that were reconstituted with Il1r1−/− bone marrow 
cells followed a weight loss curve that resembled the one observed 
in wild-type mice with a maximum of approximately 15% weight 
loss. Surprisingly, Il1r1−/− mice that were reconstituted with IL-1R 
sufficient bone marrow had a tendency to lose more weight than 
the Il1r1−/− mice that were reconstituted with IL-1R-deficient 
bone marrow (Figure  3A). We also counted the proportion of 
GC B cells in the lung. Wild-type mice with IL-1R-deficient 
hematopoietic cells were able to induce a higher proportion of 
GC B cells than Il1r1−/− mice with normal hematopoietic cells 
(Figure 3B), suggesting that IL-1 boosts the formation of iBALT 
structures by signaling to radioresistant stromal cells.
cXcl13 expression is reduced  
in Il1r1−/− Mice
To define which downstream iBALT-instructive signals are 
induced by IL-1R signaling in radioresistant cells, we measured 
the expression level of the chemokines CXCL12, CXCL13, 
CCL19, and CCL21, which all have been implicated in iBALT 
formation. The chemokines CCL19 and CCL21 instruct the 
organization of T cell zones in iBALT structures, but were not 
impaired in Il1r1−/− mice (Figure 4). The chemokine CXCL12 
is important for B cell lymphopoiesis, but expression of this 
chemokine was only slightly reduced early after infection in 
Il1r1−/− mice. The chemokine CXCL13 functions as an LTi and 
B cell chemoattractant, and its expression was reduced 4 dpi in 
Il1r1−/− mice (Figure  4). None of the chemokines involved in 
iBALT formation and organization was differentially expressed 
at 17 dpi, when iBALT had fully developed in wild-type mice, 
showing that the instructive chemokine signals are given early 
after infection when the virus is not yet cleared from the lungs. 
Although CXCL13 expression was impaired early after infection, 
the total amount of B cells in the lungs was not significantly 
altered at the time iBALT was present (Figure 1C), suggesting 
that it is not recruitment of B cells to the lungs that is impaired 
in Il1r1−/− mice but that the B cells in the lung fail to cluster into 
organized iBALT structures. Whether this is a direct or indirect 
effect of defective IL-1R signaling on stromal cells remains a 
subject for future experiments.
DiscUssiOn anD reVieW  
OF The liTeraTUre
The IL-1 axis has been described previously to be responsible 
for inflammatory pathology in the lung, resulting in increased 
mortality, increased viral titers, and neutrophil recruitment 
following IAV infection (7). Il1r1−/− mice indeed suffered more 
from the mild X31 IAV infection and displayed a tendency to 
higher viral titers in the lung, but did manage to clear infec-
tion with delayed kinetics, leading to a presumably higher viral 
exposure over time. Despite this increased viral exposure, they 
hardly formed iBALT structures in the lung. Conversely, when 
recombinant IL-1 was administered early after IAV infection to 
wild-type mice, the formation of iBALT structures was facili-
tated. Mechanistically, we found impaired CXCL13 chemokine 
induction early after infection in Il1r1−/− mice. Later, at the time 
when iBALT was fully formed in wild-type mice, we could not 
detect any differences in CXCL13 levels, suggesting that the 
instructive signals that condition the lung for clustering adap-
tive immune cells are given very early (2–4 dpi) after infection. 
By studying iBALT formation in chimeric mice, we found that 
FigUre 3 | il-1r signaling on stromal cells is necessary to induce germinal center B cells in the lung. (a) Weight loss curve after infection with X31 virus 
as percentage of the initial bodyweight for wild-type (squares) and IL-1R−/− (circles) mice reconstituted with wild-type (black) or IL-1R−/− bone marrow (white).  
(B) Proportion of germinal center B cells 17 dpi in the lungs of wild-type (squares) and IL-1R−/− (circles) mice reconstituted with wild-type (black) or IL-1R−/− bone 
marrow (white). ns, not significant. *p < 0.05. **p < 0.01.
FigUre 4 | Il1r1−/− mice have a defect in the production of the iBalT-inducing chemokine cXcl13. mRNA expression levels of the chemokines involved in 
iBALT induction: CXCL12, CXCL13, CCL19, CCL21 relative to the expression of housekeeping gene L27. The experiment was performed twice with three to five 
mice per group. ns, not significant. *p < 0.05.
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IL-1R expression on stromal cells is necessary for proper iBALT 
formation. The exact cell type of stromal cells that is needed to 
induce GC B cells, however, still needs to be defined. Whether 
this stromal cell type is directly responsible for the CXCL13 pro-
duction needed to initiate iBALT formation or an intermediate 
cell type is involved remains a matter of debate.
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As we observed a decreased induction in MoDCs and these 
cells are previously described as being major cytokine and 
chemokine producers (46), it is a possibility that these cells are 
involved in the CXCL13 induction. Alternatively, LTβ-sufficient B 
cells can support the progression toward mature, fully structured 
TLOs (35, 47) most likely via a positive feedback loop of CXCL13 
production and LTβ expression (24). According to this hypoth-
esis B cells are activated via TLR signaling, induce expression of 
LTβ on their surface, and interact on its turn with LTβR bearing 
B cells. This LTβ signaling will induce CXCL13 production and 
release, which attracts more B cells and upregulates LTβ expres-
sion. It is an attractive hypothesis that IL-1 might also induce 
LTβ expression on B cells, although this is hard to reconcile with 
our observation that a radioresistant cell type responds to IL-1 
in our model.
We can only speculate about the source of IL-1α. Previous 
research has shown that IL-1α can be released by dying cells (48). 
In this respect, virus-infected lung epithelial cells might be a 
possible source of IL-1α as it has been observed that IL-1α exerts 
feedback on epithelial cells and induces a second cytokine and 
chemokine wave during innate immune responses in the lung 
(3, 49). We have only measured the mRNA for IL-1β. Secretion 
of bioactive IL-1β requires activation of the Nlrp3 inflammasome 
that leads to activation of caspase-1 and cleavage of pro-IL-1β into 
IL-1β. Infection with IAV leads to activation of the Nlrp3 inflam-
masome in a process requiring the type I IFN-induced RNAse L/
OAS system, while the virus actively suppresses IL-1β production 
and Nlrp3 activation via the NS1 protein (4, 5). Although others 
have shown that the NLRP3 inflammasome controls severity of 
infection (9, 11, 50, 51), future studies will have to address if lack 
of key components of this inflammasome also leads to reduced 
iBALT formation.
Generally, TLOs are absent in the lungs of healthy adults (52), 
but bronchus-associated lymphoid tissue can be observed in 
the lungs of children who are frequently infected by respiratory 
viruses (53) and in the lungs of adults who suffer from rheumatoid 
arthritis (28, 54), transplant rejection (55), COPD (56), and IPAH 
(31). We can only speculate that IL-1 might also be involved in 
the formation of these TLO structures. IL-1 is certainly a cytokine 
that has been implicated in the pathogenesis of rheumatoid 
arthritis, and targeting the IL-1 pathway via IL1RA (anakinra) 
has been used as an alternative biological treatment in patients 
failing therapy on TNFα blockade. A very common risk factor for 
rheumatoid arthritis development is smoking, which also leads to 
COPD. End-stage COPD is also accompanied by TLO formation 
in the lungs, and these can be sites of production of antibodies 
to citrullinated antigens, typical of RA patients. In a preclinical 
model of smoking-induced TLO formation, the production of 
autoantibodies and TLO structures was reduced in Il1r1−/− mice, 
accompanied by a reduced CXCL13-production in the lungs (57).
During development, neuronal cells give an LTα1β2-
independent instructive signal to local fibroblasts to produce 
CXCL13 and, hereby, attract CD3−CD4+CD45+ LTi cells (58, 59). 
The crucial step for SLO development is the interaction of LTi 
cells with stromal lymphoid tissue organizer (LTo) cells. This 
process happens via interaction of LTβ expressed on LTi cells and 
the LTβR expressed on LTo cells. Upon this interaction, LTo cells 
produce homeostatic chemokines that drive the recruitment of 
lymphocytes. T cells and DCs are attracted by chemokine CC 
ligand (CCL)19 and CCL21; B cells are attracted by chemokine 
CXC ligand (CXCL)13. Expression of vascular cell adhesion 
molecule (VCAM)1, intercellular adhesion molecule (ICAM)1, 
and mucosal addressin cell adhesion molecule (MADCAM)1 
allow the attracted cells to cluster together. IL-1 has been very 
well known for its effects of stimulating adhesion molecules on 
endothelial cells (60). It is tempting to speculate that the effects 
of IL-1 on radioresistant cells is via induction of the crucial adhe-
sion molecules that initially tether a LTi-like cell to the circulation 
and subsequently to initiate a communication between stromal 
cells and lymphoid cells, that initiates the CXCL13 production.
The LTi-potential of T cells was first addressed in a model 
of thyroid overexpression of CCL21, where it was shown that 
CD3+CD4+-activated T cells interacted with DCs at sites of chronic 
inflammation and subsequently acted as LTi cells in the absence 
of Id2 activity (37). It has also been suggested that IL-17 signal-
ing is involved during the initiation phase of iBALT formation by 
inducing CXCL13, but this role for IL-17 remains controversial 
(34). In two studies on neonatal mice exposed to endotoxin 
inhalation and on mice with experimental autoimmune encepha-
lomyelitis, respectively, an activated Th17 CD4 T cell population 
was found to be involved in inducing TLO structures (34, 61). 
RORC+ IL-17-producing cells were also found inside lung TLOs 
of patients with IPAH. In humans, Th17 cells express the CCR6 
receptor, and in the bloodstream of IPAH patients circulating 
CCR6+ cells were fewer, while the ligand CCL20 was produced 
in the perivascular TLOs (31). However, TLOs seem to develop 
normally in Ccr6−/− mice (34). The induction of TLOs by Th17 
cells was dependent on expression of podoplanin, but why this 
is the case remains unknown. One possibility is that podoplanin 
is required for retention of Th17 cells at sites of TLO formation 
(34, 61). The role of Th17 as LTi-like cells is still under debate, and 
it remains to be seen whether all forms of TLO depend on IL-17 
production and whether IL-17A and/or IL-17F is involved. In this 
regard, iBALT induced by infection with modified vaccinia virus 
Ankara or influenza virus is not affected by deficiency of IL-17A, 
while Pseudomonas aeruginosa-induced iBALT is dependent on 
IL-17 signaling (35, 62). As IL-17 production by γδ T cells and 
Th17 cells can be induced by IL-1 (63–66), we also considered 
the possibility that IL-17 is part of the cascade leading to IL-1α 
driven iBALT formation. In our hands, IAV infection indeed gave 
rise to a higher amount of IL-17+ CD4 T cells, but treatment with 
IL-1α 2 dpi could not increase the amount of IL-17+ CD4 T cells 
in the lung, and experiments in which we administered IL-1 to 
IAV-infected Il17ra−/− mice were inconclusive (data not shown). 
This suggests that, in contrast to SLO formation, the instructive 
signals can differ depending on the source of initiating antigen 
or the inflammatory stimulus that is elicited by the used model.
In almost all TLO structures that have been described, the 
T cell area contained antigen-presenting DCs (17, 31). As DCs 
activate T cells, it has been suggested that DCs are sufficient 
for TLO induction (67). This hypothesis is supported by the 
observation that repeated injection of DCs into the lungs of 
mice is sufficient for induction of iBALT structures accompanied 
by induction of myofibroblast differentiation (17, 68). During 
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formation of Peyer’s patches, a CD11c+ cell type expressing LTαβ 
accumulates at the LN anlagen and is necessary for instruction 
of stromal cells (59). DCs might also directly instruct stromal 
cells irrespectively of their effects on T cells. In TLO structures 
induced in the thymus, DCs were specifically necessary for 
induction of lymph angiogenesis from stromal cells (69), but 
how DCs induce TLOs is less clear. In virus-induced iBALT, 
mainly CD11b+ DCs or monocyte-derived cells accumulate; 
these cells express instructive LTα1β2 while also producing the 
homeostatic chemokines CXCL13 and CCL19/CCL21 (17). 
However, in some models, mostly pDCs accumulate, suggesting 
a functional role for type I IFN. As is the case in TLOs found 
in end-stage COPD patients and in a murine SLE model (56, 
70). Three studies have shown that depletion of DCs leads to 
disappearance of existing TLO structures, suggesting that DCs 
are necessary for structural organization and maintenance of 
TLOs, most likely through trans-presentation of chemokines, 
or by providing a continuous source of antigen presentation 
to T cells (16, 17, 69). We did observe reduced numbers of 
monocyte-derived DCs in Il1r1−/− mice, but have not performed 
experiments in which only DCs lacked IL-1R to study if the 
effects of IL-1 were cell-intrinsic or resulting from effects of IL-1 
on epithelial cells. Indeed, IL-1R triggering on lung epithelial 
cells is a very well-known trigger for the production of GM-CSF, 
one of the major cytokines driving activation of monocytes to 
adopt a DC-like phenotype (49).
In conclusion, we have described a novel role for early IL-1 
production in IAV infection to control the formation of iBALT 
structures via induction of CXCL13 in a stromal cell compart-
ment. Future studies will have to address if this effect of one of the 
best-known proinflammatory and innate cytokines is a general 
feature of TLO formation at sites of acute and chronic immune 
stimulation such as infectious disease and autoimmune patholo-
gies and if this can be exploited to induce iBALT formation as 
part of a mucosal vaccination strategy (71).
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